RCC
Clinical trials for RCC explained in plain language.
Never miss a new study
Get alerted when new RCC trials appear
Sign up with your email to follow new studies for RCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New strategy to fight kidney cancer when first treatment fails
Disease control Recruiting nowThis study is testing if giving a higher dose of the drug cabozantinib can help control advanced kidney cancer in patients whose cancer has started growing again while on the standard dose. The trial will enroll 18 adults with advanced kidney cancer who previously benefited from …
Matched conditions: RCC
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug trial begins for Tough-to-Treat kidney cancer
Disease control Recruiting nowThis is the first study in people testing a new oral drug called NEO-811 for advanced kidney cancer that has spread or cannot be removed by surgery. The main goals are to find a safe dose and see how the body handles the drug. It is for patients whose cancer has continued to grow…
Matched conditions: RCC
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Smart cell therapy aims to target cancer while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of cell therapy called A2B395 for adults with advanced solid tumors that have spread or returned. The therapy uses modified immune cells designed to specifically kill cancer cells while protecting the patient's healthy cells. The main goals are to…
Matched conditions: RCC
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Blood test could spot kidney cancer return before scans do
Knowledge-focused Recruiting nowThis study is testing a new type of blood test to see if it can detect the return of kidney cancer earlier than current standard scans. It will follow 450 patients who are having surgery for newly diagnosed kidney cancer. Researchers will track changes in genetic markers in the b…
Matched conditions: RCC
Sponsor: Jinling Hospital, China • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC